Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cryptococcal virulence: beyond the usual suspects.

Aaron P Mitchell1

  • 1Department of Microbiology, Columbia University, New York, New York 10032, USA. apm4@columbia.edu

The Journal of Clinical Investigation
|June 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Timeliness of Prostate Cancer Treatment in Medicare Advantage and Traditional Medicare: More Similarities than Differences?

JCO oncology practice·2026
Same author

Shared anti-biofilm targets of biofilm regulators Wor3 and Bcr1 in Candida albicans.

Genetics·2026
Same author

Negative control of Candida albicans biofilm formation by combined action of white-opaque regulator Wor2 and biofilm regulator Bcr1.

G3 (Bethesda, Md.)·2026
Same author

When Priority Review No Longer Prioritizes.

JCO oncology practice·2026
Same author

Use of Low-Value Cancer Care in Practices Acquired by Private Equity Firms.

Journal of the National Cancer Institute·2026
Same author

Impact of <i>Candida albicans NDT80</i> and <i>UME6</i> on biofilm formation and fluconazole susceptibility.

mSphere·2026
Same journal

Extracellular matrix reprogramming by the YAP/TAZ- TGF-ß2 axis drives immune exclusion in cholangiocarcinoma models.

The Journal of clinical investigation·2026
Same journal

Tumor cell-derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer.

The Journal of clinical investigation·2026
Same journal

Julie Zikherman receives the ASCI/Marian W. Ropes, MD, Award.

The Journal of clinical investigation·2026
Same journal

Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models.

The Journal of clinical investigation·2026
Same journal

SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2.

The Journal of clinical investigation·2026
Same journal

MDM2 degraders for Merkel cell carcinoma: round peg in a round hole.

The Journal of clinical investigation·2026
See all related articles

Cryptococcus neoformans requires glucosylceramide (GlcCer) for growth in host environments. This finding reveals GlcCer

Area of Science:

  • Mycology
  • Infectious Diseases
  • Cell Biology

Background:

  • Cryptococcal infection is a major cause of mortality in immunocompromised individuals.
  • The fungal cell surface plays a critical role in host-pathogen interactions.
  • Understanding the environmental adaptations of Cryptococcus neoformans is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the role of glucosylceramide (GlcCer) in the pathogenicity of Cryptococcus neoformans.
  • To elucidate the relationship between GlcCer and fungal adaptation to host physiological conditions.

Main Methods:

  • Generating and characterizing a glucosylceramide (GlcCer) mutant of Cryptococcus neoformans.
  • Assessing fungal growth and survival in various host-mimicking environments.

Related Experiment Videos

  • Analyzing the impact of host CO2 and pH on fungal GlcCer expression and pathogenicity.

    • Main Results:

    • The GlcCer mutant exhibited significantly reduced pathogenicity compared to the wild-type strain.
    • GlcCer is essential for Cryptococcus neoformans survival and growth in neutral pH environments, such as the bloodstream and lung alveoli.
    • GlcCer expression is linked to fungal responses to physiological CO2 and pH levels.

    Conclusions:

    • Cell surface glucosphingolipid GlcCer is vital for Cryptococcus neoformans to overcome host defense mechanisms and establish infection.
    • Targeting GlcCer presents a potential therapeutic strategy for cryptococcal infections.
    • Further research into anti-GlcCer antibodies may lead to novel treatment options.